Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma

Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging

(2017) James K. Lui et al.   JOURNAL OF ALZHEIMERS DISEASE

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

(2015) Vincent Chouraki et al.   Alzheimers & Dementia

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

(2015) Kaj Blennow et al.   Alzheimers & Dementia

Association of plasma β-amyloid with MRI markers of structural brain aging the 3-City Dijon study

(2015) Sara Kaffashian et al.   NEUROBIOLOGY OF AGING

Chasing the Effects of Pre-Analytical Confounders – A Multicenter Study on CSF-AD Biomarkers

(2015) Maria João Leitão et al.   Frontiers in Neurology

A Practical Guide to Immunoassay Method Validation

(2015) Ulf Andreasson et al.   Frontiers in Neurology

Amyloid-β efflux from the central nervous system into the plasma

(2014) Kaleigh Filisa Roberts et al.   ANNALS OF NEUROLOGY

Identification of an important potential confound in CSF AD studies: aliquot volume

(2013) Jamie Toombs et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

(2013) Victor L Villemagne et al.   LANCET NEUROLOGY

Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker

(2013) Jon B Toledo et al.   Alzheimers Research & Therapy

Plasma Amyloid-β as a Predictor of Dementia and Cognitive Decline

(2012) Alain Koyama et al.   ARCHIVES OF NEUROLOGY

Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease

(2012) Anne M Fagan et al.   Biomarkers in Medicine

Pyroglutamate Amyloid β (Aβ) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease

(2012) Jessica L. Wittnam et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

(2011) Jon B. Toledo et al.   ACTA NEUROPATHOLOGICA

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

(2011) Hugo Vanderstichele et al.   Alzheimers & Dementia

Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline

(2011) Kristine Yaffe   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Plasma A 42 and A 40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study

(2010) T. T. Seppala et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Change in plasma A  peptides and onset of dementia in adults with Down syndrome

(2010) N. Schupf et al.   NEUROLOGY

N-terminal truncated pyroglutamyl β amyloid peptide Aβpy3-42 shows a faster aggregation kinetics than the full-length Aβ1-42

(2009) Cristina D'Arrigo et al.   BIOPOLYMERS

Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease

(2009) R. Deane et al.   CNS & Neurological Disorders-Drug Targets

Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum

(2009) Philine Schneider et al.   CNS Neuroscience & Therapeutics

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

(2009) P. Lewczuk et al.   EXPERIMENTAL NEUROLOGY

The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma β-amyloid isoforms using the INNO-BIA plasma Aβ forms multiplex assay

(2009) D. R. Lachno et al.   Journal of Nutrition Health & Aging

Evolution of Aβ42 and Aβ40 levels and Aβ42/Aβ40 ratio in plasma during progression of Alzheimer’s disease: A multicenter assessment

(2009) K. Blennow et al.   Journal of Nutrition Health & Aging

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men

(2008) Johan Sundelöf et al.   ARCHIVES OF NEUROLOGY

CSF biomarker levels in early and late onset Alzheimer's disease

(2008) Femke H. Bouwman et al.   NEUROBIOLOGY OF AGING

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

(2008) Oskar Hansson et al.   NEUROBIOLOGY OF AGING

Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

(2007) Harald Hampel et al.   Alzheimers & Dementia